COR vs TMO · P/E 21, rev $321.33B vs P/E 24, rev $44.56B
Cencora Inc. (COR) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
COR currently screens at market cap $53.91B and trailing P/E 21.2. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the COR and TMO stock pages for the full models.
Not investment advice.